Navigation Links
Navitas Opens New Cancer Rehabilitation Center in Albuquerque in Conjunction With New Mexico Cancer Centers
Date:9/12/2007

DENVER, Sept. 12 /PRNewswire/ -- Navitas Cancer Rehabilitation Centers of America, Inc. ("Navitas"), the market leader in providing integrated and comprehensive cancer rehabilitation services, is pleased to announce that it has opened a new center in Albuquerque, New Mexico. The Albuquerque Center has been established in cooperation with New Mexico Oncology Hematology Consultants, Ltd., (NMOHC) the largest independent oncology and hematology practice in the State of New Mexico. Within the Albuquerque Center, Navitas provides an integrated set of rehabilitation services designed specifically for cancer patients and survivors. These services include physical therapy, prescriptive exercise, lymphedema therapy, and psychological services, among others, all provided within a single location and in a highly personalized and integrated manner.

While initially operating at 7007 Wyoming Boulevard NE, the Center will be permanently housed within the New Mexico Cancer Center, NMOHC's largest practice location, by the fourth quarter of 2007. The Center will be able to provide services to hundreds of people undergoing cancer treatment and will employ a team of clinicians and rehabilitative specialists from various disciplines. The Albuquerque site marks the third Navitas location, joining the company's others in Denver, Colorado and Salt Lake City, Utah.

"We are excited to expand our services to the cancer patients and survivors in New Mexico," said Paul Barnes, Ph.D., President and CEO for Navitas. "Our relationship with NMOHCC gives us a great opportunity to deliver needed rehabilitative services to patients in conjunction with their cancer treatment. We believe our services will allow patients to better tolerate their cancer treatment, provide significant relief from the side effects of cancer and its treatment, and help ease the transition to cancer survivorship, both physically and emotionally."

"Navitas brings a long-needed set of rehabilitative services that will complement the cancer care that our oncologists provide, "said Barbara McAneny, M.D., CEO of NMOHCC and Board Member of the American Society of Clinical Oncology. The fact that the Navitas protocols are evidence-based and built specifically for cancer patients was a critical factor for our decision to support this program. I think the co-location in our cancer center in the fall will only increase our ability to integrate care."

About Navitas Cancer Rehabilitation Centers of America

Founded in 2003, Navitas Cancer Rehabilitation Centers of America (http://www.navitasinc.com) developed an evidence-based approach to providing rehabilitation and supportive therapies to people with cancer. Navitas provides these services on a free-standing basis as well as through community-based and hospital-based oncology centers and practices. The Navitas vision is to make supportive and rehabilitation services a standard component of the cancer treatment plan through the development of a robust, multi-disciplinary clinical program and demonstrated outcomes for patients and physicians. Navitas is headquartered in Denver, Colorado.

http://www.navitasinc.com

About The New Mexico Cancer Center

The physicians of the New Mexico Oncology Hematology Consultants, Ltd comprise NMOHCC. It is Albuquerque's first freestanding cancer treatment facility and provides multidisciplinary cancer treatments, including chemotherapy and radiation. NMOHCC is committed to bringing state-of-the-art technology and the latest therapies to cancer patients throughout New Mexico. The medical team practices in several regions of the state, including Albuquerque, Silver City, Farmington, Ruidoso, and Gallup.

http://www.nmcancercenter.com

Media Contact:

Paul Barnes

303-865-7840

pbarnes@navitasinc.com


'/>"/>
SOURCE Navitas Cancer Rehabilitation Centers of America, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. First global SARS meet opens
2. Cancer Drug Opens Arteries
3. Ranbaxy opens Drug discovery centre in Gurgaon
4. Delhi Hospital Opens Up Avenues For Computer-Aided Knee Replacement
5. Cancer Hospice Opens New In-patient Unit
6. Center for Celiac Disease Opens
7. Review Opens Bag of Tricks for Reducing Pain from Children’s Shot
8. Apollo Eyes Expansion in Kolkata, Opens Ayurveda Clinic
9. Largest Ever African HIV Vaccine Trial Opens in South Africa
10. Apollo Opens Blood Cancer Clinic in Kolkata
11. China Opens Doors For Foreign Investments In Hospitals Care System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s ... together more than 200 of the country’s top healthcare executives to share insights ... true benefit of the Forum is the provider-centric perspective, experience, expertise and strategy ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience signed a ... network of laboratory service centers across the country. Launched in April of 2015, Apifiny ... detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary care ...
(Date:2/10/2016)... ... February 10, 2016 , ... A ... Ohio Safety Congress and Expo event March 9-11, 2016. Hosted by Ohio's Bureau ... Center. , As the longest running and largest worker's compensation event in ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... 1 UNF Drive, Jacksonville, FL 32224, February 26th: Amateur & Professional Divisions ... Division - Time: 7:00pm – 10:00pm | Ticket Prices $30, Social Media: ...
(Date:2/10/2016)... ... February 10, 2016 , ... Anxiety of older Americans ... start of Medicare Part D a decade ago, according to The Senior Citizens ... adults on how they are coping with rapidly rising costs. “The implications are ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
(Date:2/10/2016)...  Rich Pharmaceuticals, Inc. (OTC Markets: RCHA) ("Rich Pharmaceuticals" ... of its issued and outstanding shares of common stock ... 11, 2016. The Company,s common stock will trade on ... temporary ticker symbol "RCHAD". After 20 trading days, the ... (RCHA).  --> --> ...
(Date:2/10/2016)... , Feb. 10, 2016  The Baylor ... received an in-kind gift from ... VeinViewer® Vision vein finder for the nursing ... students as they learn how to start ... with traditional technique. ...
Breaking Medicine Technology: